A newspaper is reporting that three Indian drug companies have already begun making a knockoff of sanofi-aventis' obesity drug Acomplia. And at least one of the companies says it will launch the generic competitor in any countries where it would be allowed by law. Indian law protects only those drugs patented after 1995, and Acomplia's patent dates to 1994. Report